FDA OK's Silvergate's Epaned; new ped hypertension option

The US FDA has granted Silvergate Pharmaceuticals approval to market Epaned (enalapril maleate) powder for oral solution to treat high blood pressure for patients as young as one month – providing not only a new option for adults who may have difficulty swallowing pills, but also for babies and children with pediatric hypertension.

The US FDA has granted Silvergate Pharmaceuticals approval to market Epaned (enalapril maleate) powder for oral solution to treat high blood pressure for patients as young as one month – providing not only a new option for adults who may have difficulty swallowing pills, but also for babies and children with pediatric hypertension.

As an oral solution formulation, Epaned enables accurate dosing and has a taste that appeals to children, which may help...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Alimentary/Metabolic

More from Therapeutic Category